Beetroot Red Food Color Gets Temporary Government Timeout
Published Date: 3/24/2026
Rule
Summary
The FDA is hitting the pause button on the new rule that lets food makers use beetroot red as a color in most foods. This delay happens because some folks raised concerns, so the FDA needs more time to review before making it official. No money changes yet, but food companies and consumers will have to wait a bit longer for this colorful update.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Beetroot Red Use Delayed for Food Makers
As of March 20, 2026, the FDA has delayed indefinitely the February 6, 2026 final order that would have allowed food makers to use beetroot red (added as 21 CFR 73.39) for coloring human foods generally. The delay was triggered by timely objections (including a submission dated March 5, 2026) and legally prevents the final order from taking effect until FDA resolves those objections or announces a new effective date.
Consumers Face Delay in Beetroot Red Foods
You will not see foods newly colored with beetroot red under the February 6, 2026 final order while the FDA has delayed the order as of March 20, 2026. The delay is indefinite and will remain in place until FDA publishes a document announcing a new effective date or other administrative action.
FDA Safety Finding Remains Intact
The FDA says its scientific determination that there is a "reasonable certainty of no harm" from beetroot red under the proposed conditions of use has not changed, even though the effective date of the rule is delayed as of March 20, 2026. FDA also says it will address the filed objections in a future document.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06478 — Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY
The FDA has officially set the review period for VYLOY, a human biological product, so its patent holder can apply for extra patent time. This affects the company behind VYLOY, giving them a chance to extend their patent protection and potentially boost profits. If anyone thinks the dates are wrong or wants to challenge the company’s review speed, they must act by June 2 or September 30, 2026.
2026-06481 — Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI
The FDA has set the official review period for HYMPAVZI, a new human biological product, so its patent holder can apply for extra patent time. This affects the company behind HYMPAVZI and anyone interested in patent extensions. If you think the dates are wrong or want to challenge the company’s diligence, you have until June 2 or September 30, 2026, to speak up—potentially impacting patent length and market exclusivity.
2026-06480 — Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS
The FDA has officially set the review period for EMRELIS, a medicine patent, so the patent owner can apply for extra protection time. If anyone thinks the dates are wrong, they have until June 2, 2026, to speak up. Also, people can challenge whether the patent owner was diligent during the review by September 30, 2026. This affects patent holders and could impact how long they keep exclusive rights to their product.
2026-06479 — Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA
The FDA has set the official review period for ENFLONSIA, a human biological product, so its patent holder can apply for extra patent time. This affects the company behind ENFLONSIA and anyone interested in patent rules. If you think the dates are wrong or want to challenge the company’s review speed, you have until June 2 or September 30, 2026, to speak up—potentially impacting patent length and market exclusivity.
2026-06477 — Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO
The FDA has officially set the review period for ENCELTO, a medicine patent, so the company can apply to extend its patent protection. This affects the drug maker by potentially giving them more time to exclusively sell ENCELTO, which can mean more money. If anyone thinks the dates are wrong or the company wasn’t diligent, they have until June 2 or September 30, 2026, to speak up.
2026-06483 — Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER
The FDA has officially set the review period for INJECTAFER, a drug patent up for extension. This means the company can apply to extend their patent protection, potentially keeping their exclusive rights longer and impacting competition and pricing. If anyone thinks the dates are wrong or the company wasn’t diligent, they can speak up by June 2 or September 30, 2026.
Previous / Next Documents
Previous: 2026-05731 — Establishment of the Nine Lakes of East Tennessee Viticultural Area
Starting April 23, 2026, the Nine Lakes of East Tennessee becomes an official wine region, covering over 4,000 square miles in northeastern Tennessee. This new American Viticultural Area (AVA) helps local winemakers proudly label their wines with a unique origin, making it easier for wine lovers to find and enjoy wines from this special spot. No extra costs or changes for consumers, just a fresh new name on the wine map!
Next: 2026-05733 — Listing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date
The FDA is hitting the pause button on the new rules about using spirulina extract as a food color. This delay affects food makers who were ready to use spirulina more widely but now have to wait because some folks asked for a review. No safety worries yet, but the new rules won’t kick in until the FDA sorts things out, so no changes or costs happen just yet.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in